company background image
BIOX logo

Bioceres Crop Solutions NasdaqGS:BIOX 주식 보고서

최종 가격

US$6.46

시가총액

US$399.7m

7D

-5.6%

1Y

-46.1%

업데이트

20 Nov, 2024

데이터

회사 재무 +

Bioceres Crop Solutions Corp.

NasdaqGS:BIOX 주식 보고서

시가총액: US$399.7m

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Bioceres Crop Solutions Corp. 경쟁사

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Bioceres Crop Solutions
과거 주가
현재 주가US$6.46
52주 최고치US$14.05
52주 최저치US$5.71
베타0.47
11개월 변경-12.94%
3개월 변경 사항-34.88%
1년 변경 사항-46.08%
33년 변화-56.82%
5년 변화11.38%
IPO 이후 변화31.84%

최근 뉴스 및 업데이트

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Recent updates

Bioceres Is Getting Cheaper, Not Yet An Opportunity But More Interesting

Nov 13

Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Sep 28
Take Care Before Jumping Onto Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Even Though It's 29% Cheaper

Bioceres' Q4 2024 Shows Challenges With HB4 Rollout, Still A Hold Despite Lower Stock Prices

Sep 17

These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Aug 03
These 4 Measures Indicate That Bioceres Crop Solutions (NASDAQ:BIOX) Is Using Debt Extensively

Bioceres Needs To Add Clarity Around Borrowings

Mar 23

Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Feb 03
Bioceres Crop Solutions (NASDAQ:BIOX) Takes On Some Risk With Its Use Of Debt

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Oct 04
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Jun 21
Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Popularity With Investors Is Clear

Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

May 09
Here's Why Bioceres Crop Solutions (NASDAQ:BIOX) Is Weighed Down By Its Debt Load

Bioceres: A Resilient Small Cap With Conference Appearances After Thursday's Earnings

Sep 06

Bioceres Crop Solutions jumps 15% after investor pitch

Aug 23

We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Apr 10
We Think Bioceres Crop Solutions (NASDAQ:BIOX) Is Taking Some Risk With Its Debt

Bioceres Has Not Resolved Its Major Risks And Is Growing Based On Commodities Bullishness

Mar 31

Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Mar 17
Is Now The Time To Look At Buying Bioceres Crop Solutions Corp. (NASDAQ:BIOX)?

Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Nov 13
Is Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Trading At A 21% Discount?

Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Jul 08
Bioceres Crop Solutions (NASDAQ:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Jun 16
Estimating The Intrinsic Value Of Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

May 26
What Does Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Share Price Indicate?

Bioceres partners with Havanna to offer consumers HB4 wheat-based sustainable products

May 10

Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

May 05
Does Bioceres Crop Solutions (NASDAQ:BIOX) Have A Healthy Balance Sheet?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Apr 05
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Will Want The ROCE Trajectory To Continue

Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Mar 10
Are Investors Undervaluing Bioceres Crop Solutions Corp. (NYSEMKT:BIOX) By 22%?

Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

Feb 12
Bioceres Crop Solutions (NYSEMKT:BIOX) Shareholders Booked A 53% Gain In The Last Year

주주 수익률

BIOXUS ChemicalsUS 마켓
7D-5.6%-1.1%-1.0%
1Y-46.1%9.8%30.3%

수익률 대 산업: BIOX 지난 1년 동안 9.8 %를 반환한 US Chemicals 업계보다 저조한 성과를 냈습니다.

수익률 대 시장: BIOX 지난 1년 동안 30.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.

가격 변동성

Is BIOX's price volatile compared to industry and market?
BIOX volatility
BIOX Average Weekly Movement6.4%
Chemicals Industry Average Movement5.4%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

안정적인 주가: BIOX 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.

시간에 따른 변동성: BIOX 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립직원CEO웹사이트
2001n/aFederico Truccoinvestors.biocerescrops.com/home/default.aspx

바이오세레스 크롭 솔루션즈는 자회사와 함께 작물 생산성 솔루션을 제공합니다. 종자 및 통합 제품, 작물 보호 및 작물 영양 부문을 통해 운영됩니다. 종자 및 통합 제품 부문은 더 건강하고 수확량이 많은 작물을 위한 종자 형질, 생식세포, 종자 처리 팩을 제공합니다.

Bioceres Crop Solutions Corp. 기본 사항 요약

Bioceres Crop Solutions 의 수익과 매출은 시가총액과 어떻게 비교하나요?
BIOX 기본 통계
시가총액US$399.72m
수익(TTM)US$2.44m
수익(TTM)US$441.23m

166.2x

P/E 비율

0.9x

P/S 비율

BIOX 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
BIOX 손익 계산서(TTM)
수익US$441.23m
수익 비용US$265.14m
총 이익US$176.09m
기타 비용US$173.65m
수익US$2.44m

최근 보고된 수익

Sep 30, 2024

다음 수익 날짜

n/a

주당 순이익(EPS)0.039
총 마진39.91%
순이익 마진0.55%
부채/자본 비율72.3%

BIOX 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기